Camp4 Therapeutics Corp SEC filings CAMP

Camp4 Therapeutics Corp has 192 filings in SEC EDGAR's recent list, going back to Sep 25, 2018. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.

Camp4 Therapeutics Corp SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report Nov 5, 2026 Nov 5, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Sep 28, 2026 Sep 28, 2026
4 Insider transaction Sep 2, 2026 Aug 31, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 31, 2026 —
4 Insider transaction Aug 31, 2026 Aug 27, 2026
4 Insider transaction Aug 26, 2026 Aug 24, 2026
4 Insider transaction Aug 21, 2026 Aug 19, 2026
4 Insider transaction Aug 19, 2026 Aug 19, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 19, 2026 —
144 Notice of proposed sale Aug 19, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
EFFECT Filing Aug 12, 2026 —
424B3 Prospectus Aug 12, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 10, 2026 —
S-3 Shelf registration Aug 6, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 5, 2026 —
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Aug 4, 2026 Aug 3, 2026
8-K Current report
Regulation FD disclosure, Other events
Jul 27, 2026 Jul 27, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
4 Insider transaction Jun 12, 2026 Jun 10, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 12, 2026 Jun 10, 2026
SCHEDULE 13G Ownership over 5% (passive) May 15, 2026 —
8-K Current report
Regulation FD disclosure
May 14, 2026 May 14, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 23, 2026 —
DEF 14A Proxy statement Apr 23, 2026 Jun 10, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
3 Initial insider ownership Apr 3, 2026 Apr 1, 2026
8-K Current report
Officer or director change
Mar 24, 2026 Mar 18, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 11, 2026 —
S-8 Employee stock plan registration Mar 5, 2026 —
10-K Annual report Mar 5, 2026 Dec 31, 2025
8-K Current report
Acquisition or sale of assets, Regulation FD disclosure
Mar 5, 2026 Mar 5, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2026 —
8-K Current report
Regulation FD disclosure
Jan 9, 2026 Jan 9, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 8, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 23, 2025 —
8-K Current report
Material agreement, Agreement ended
Dec 23, 2025 Dec 22, 2025
4 Insider transaction Dec 22, 2025 Dec 11, 2025
4 Insider transaction Dec 22, 2025 Dec 11, 2025
4 Insider transaction Dec 22, 2025 Dec 11, 2025
4 Insider transaction Dec 22, 2025 Dec 11, 2025
8-K Current report
Material agreement
Dec 18, 2025 Dec 18, 2025
424B5 Prospectus supplement Dec 18, 2025 —
FWP Free writing prospectus Dec 18, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Dec 18, 2025 Dec 17, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Dec 11, 2025 —
424B5 Prospectus supplement Dec 1, 2025 —
424B3 Prospectus Nov 25, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
S-3 Shelf registration Nov 10, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 7, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
S-3 Shelf registration Nov 3, 2025 —
3 Initial insider ownership Oct 10, 2025 Oct 1, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 7, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 1, 2025 —
8-K Current report
Regulation FD disclosure
Oct 1, 2025 Oct 1, 2025
SCHEDULE 13G Ownership over 5% (passive) Sep 17, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Sep 16, 2025 —
4 Insider transaction Sep 15, 2025 Sep 11, 2025
4 Insider transaction Sep 15, 2025 Sep 11, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 15, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 11, 2025 —
4 Insider transaction Sep 11, 2025 Sep 11, 2025
4 Insider transaction Sep 11, 2025 Sep 11, 2025
4 Insider transaction Sep 11, 2025 Sep 11, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 11, 2025 —
4 Insider transaction Sep 11, 2025 Sep 11, 2025
4 Insider transaction Sep 11, 2025 Sep 11, 2025
4 Insider transaction Sep 11, 2025 Sep 11, 2025
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
Sep 10, 2025 Sep 9, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
4 Insider transaction Jun 27, 2025 Jun 25, 2025
8-K Current report
Shareholder vote results
Jun 13, 2025 Jun 11, 2025
8-K Current report
Regulation FD disclosure
May 16, 2025 May 16, 2025
SCHEDULE 13G Ownership over 5% (passive) May 14, 2025 —
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 30, 2025 —
DEF 14A Proxy statement Apr 30, 2025 Jun 11, 2025
3/A Form 3/a Apr 11, 2025 Mar 17, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
S-8 Employee stock plan registration Mar 27, 2025 —
10-K Annual report Mar 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 27, 2025 Mar 27, 2025
4 Insider transaction Mar 19, 2025 Mar 17, 2025
4 Insider transaction Mar 19, 2025 Mar 17, 2025
3 Initial insider ownership Mar 19, 2025 Mar 17, 2025
3 Initial insider ownership Mar 19, 2025 Mar 17, 2025
8-K Current report
Officer or director change
Mar 18, 2025 Mar 12, 2025
8-K Current report
Regulation FD disclosure, Other events
Jan 7, 2025 Jan 7, 2025
10-Q Quarterly report Nov 21, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 21, 2024 Nov 21, 2024
SC 13G Ownership over 5% (passive) Oct 22, 2024 —
SC 13D Ownership over 5% (active) Oct 22, 2024 —
4/A Filing Oct 22, 2024 Oct 15, 2024
3/A Filing Oct 22, 2024 Oct 15, 2024
SC 13G Ownership over 5% (passive) Oct 22, 2024 —
SC 13D Ownership over 5% (active) Oct 22, 2024 —
SC 13D Ownership over 5% (active) Oct 22, 2024 —
4 Insider transaction Oct 17, 2024 Oct 15, 2024
4 Insider transaction Oct 17, 2024 Oct 15, 2024
4 Insider transaction Oct 17, 2024 Oct 15, 2024
SEC STAFF LETTER Filing Oct 16, 2024 —
S-8 Employee stock plan registration Oct 16, 2024 —
4 Insider transaction Oct 15, 2024 Oct 15, 2024
4 Insider transaction Oct 15, 2024 Oct 15, 2024
4 Insider transaction Oct 15, 2024 Oct 15, 2024
4 Insider transaction Oct 15, 2024 Oct 15, 2024
4 Insider transaction Oct 15, 2024 Oct 15, 2024
4 Insider transaction Oct 15, 2024 Oct 15, 2024
4 Insider transaction Oct 15, 2024 Oct 15, 2024
3 Initial insider ownership Oct 15, 2024 Oct 15, 2024
8-K Current report
Bylaw or fiscal year change
Oct 15, 2024 Oct 15, 2024
424B4 Prospectus Oct 11, 2024 —
EFFECT Filing Oct 10, 2024 —
3 Initial insider ownership Oct 10, 2024 Oct 10, 2024
3 Initial insider ownership Oct 10, 2024 Oct 10, 2024
3 Initial insider ownership Oct 10, 2024 Oct 10, 2024
3 Initial insider ownership Oct 10, 2024 Oct 10, 2024
3 Initial insider ownership Oct 10, 2024 Oct 10, 2024
3 Initial insider ownership Oct 10, 2024 Oct 10, 2024
3 Initial insider ownership Oct 10, 2024 Oct 10, 2024
3 Initial insider ownership Oct 10, 2024 Oct 10, 2024
3 Initial insider ownership Oct 10, 2024 Oct 10, 2024
3 Initial insider ownership Oct 10, 2024 Oct 10, 2024
3 Initial insider ownership Oct 10, 2024 Oct 10, 2024
3 Initial insider ownership Oct 10, 2024 Oct 10, 2024
3 Initial insider ownership Oct 10, 2024 Oct 10, 2024
3 Initial insider ownership Oct 10, 2024 Oct 10, 2024
3 Initial insider ownership Oct 10, 2024 Oct 10, 2024
3 Initial insider ownership Oct 10, 2024 Oct 10, 2024
3 Initial insider ownership Oct 10, 2024 Oct 10, 2024
3 Initial insider ownership Oct 10, 2024 Oct 10, 2024
CERT Filing Oct 10, 2024 —
8-A12B Form 8-a12b Oct 8, 2024 —
CORRESP Letter to the SEC Oct 8, 2024 —
CORRESP Letter to the SEC Oct 8, 2024 —
S-1/A Amended registration statement Oct 7, 2024 —
CORRESP Letter to the SEC Oct 2, 2024 —
UPLOAD Letter from the SEC Oct 2, 2024 —
S-1/A Amended registration statement Sep 26, 2024 —
S-1 Registration statement Sep 20, 2024 —
DRSLTR Filing Aug 22, 2024 —
DRS/A Filing Aug 22, 2024 —
SEC STAFF LETTER Filing Aug 15, 2024 —
UPLOAD Letter from the SEC Aug 13, 2024 —
DRS/A Filing Aug 2, 2024 —
DRSLTR Filing Jul 26, 2024 —
DRS/A Filing Jul 26, 2024 —
UPLOAD Letter from the SEC Jul 15, 2024 —
DRS Filing Jun 14, 2024 —
D Filing Jun 21, 2022 —
D/A Filing Oct 29, 2021 —
D Filing Mar 19, 2021 —
D Filing Sep 25, 2018 —

Showing 192 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CAMP (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Watertown, MA
SEC filer status
, Emerging growth company
SEC CIK
1736730

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.